Literature DB >> 22689447

Bioinspired total synthesis of agelastatin A.

Jeremy Chris P Reyes1, Daniel Romo.   

Abstract

A one-two punch: two potentially biosynthetically relevant cyclizations of a keramadine analogue give agelastatin A. A diastereoselective C-ring formation, which proceeds through a 5-exo-trig cyclization or a Nazarov cyclization of a red-colored N-acyliminium intermediate, generates the three contiguous stereocenters of the cyclopentane core. A silica gel assisted cyclization of a nagelamide J analogue gives agelastatin A.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22689447      PMCID: PMC3815442          DOI: 10.1002/anie.201200959

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  32 in total

1.  Enantioselective strategy to the spirocyclic core of Palau'amine and related bisguanidine marine alkaloids.

Authors:  A S Dilley; D Romo
Journal:  Org Lett       Date:  2001-05-17       Impact factor: 6.005

2.  Enantiospecific formal total synthesis of the tumor and GSK-3 beta inhibiting alkaloid, (-)-agelastatin A.

Authors:  Karl J Hale; Mathias M Domostoj; Derek A Tocher; Ed Irving; Feodor Scheinmann
Journal:  Org Lett       Date:  2003-08-07       Impact factor: 6.005

3.  New total synthesis of the marine antitumor alkaloid (-)-agelastatin A.

Authors:  Mathias M Domostoj; Ed Irving; Feodor Scheinmann; Karl J Hale
Journal:  Org Lett       Date:  2004-07-22       Impact factor: 6.005

4.  A powerful Brønsted acid catalyst for the organocatalytic asymmetric transfer hydrogenation of imines.

Authors:  Sebastian Hoffmann; Abdul Majeed Seayad; Benjamin List
Journal:  Angew Chem Int Ed Engl       Date:  2005-12-01       Impact factor: 15.336

5.  Antineoplastic agents 470. Absolute configuration of the marine sponge bromopyrrole agelastatin A.

Authors:  George R Pettit; Sylvie Ducki; Delbert L Herald; Dennis L Doubek; Jean M Schmidt; Jean-Charles Chapuis
Journal:  Oncol Res       Date:  2005       Impact factor: 5.574

6.  Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent.

Authors:  L Meijer; A M Thunnissen; A W White; M Garnier; M Nikolic; L H Tsai; J Walter; K E Cleverley; P C Salinas; Y Z Wu; J Biernat; E M Mandelkow; S H Kim; G R Pettit
Journal:  Chem Biol       Date:  2000-01

7.  New class of nucleophiles for palladium-catalyzed asymmetric allylic alkylation. Total synthesis of agelastatin A.

Authors:  Barry M Trost; Guangbin Dong
Journal:  J Am Chem Soc       Date:  2006-05-10       Impact factor: 15.419

8.  Asymmetric total synthesis of (-)-agelastatin a using sulfinimine (N-sulfinyl imine) derived methodologies.

Authors:  Franklin A Davis; Jianghe Deng
Journal:  Org Lett       Date:  2005-02-17       Impact factor: 6.005

9.  Alkynyliodonium salts in organic synthesis. Application to the total synthesis of (-)-agelastatin A and (-)-agelastatin B.

Authors:  Ken S Feldman; Joe C Saunders
Journal:  J Am Chem Soc       Date:  2002-08-07       Impact factor: 15.419

10.  Alkynyliodonium salts in organic synthesis. Development of a unified strategy for the syntheses of (-)-agelastatin A and (-)-agelastatin B.

Authors:  Ken S Feldman; Joe C Saunders; Michelle Laci Wrobleski
Journal:  J Org Chem       Date:  2002-10-04       Impact factor: 4.354

View more
  12 in total

1.  Generation and Reactivity of 2-Amido-1,3-diaminoallyl Cations: Cyclic Guanidine Annulations via Net (3 + 2) and (4 + 3) Cycloadditions.

Authors:  V Raghavendra Rao Kovvuri; Haoran Xue; Daniel Romo
Journal:  Org Lett       Date:  2020-02-03       Impact factor: 6.005

2.  Syntheses of Cyclic Guanidine-Containing Natural Products.

Authors:  Yuyong Ma; Saptarshi De; Chuo Chen
Journal:  Tetrahedron       Date:  2015-02-25       Impact factor: 2.457

3.  Synthesis and Evaluation of Agelastatin Derivatives as Potent Modulators for Cancer Invasion and Metastasis.

Authors:  Alyssa H Antropow; Kun Xu; Rachel J Buchsbaum; Mohammad Movassaghi
Journal:  J Org Chem       Date:  2017-07-25       Impact factor: 4.354

4.  Synthesis and anticancer activity of all known (-)-agelastatin alkaloids.

Authors:  Sunkyu Han; Dustin S Siegel; Karen C Morrison; Paul J Hergenrother; Mohammad Movassaghi
Journal:  J Org Chem       Date:  2013-11-21       Impact factor: 4.354

5.  Synthesis of Pyrrolopyrazinones by Construction of the Pyrrole Ring onto an Intact Diketopiperazine.

Authors:  Susanna K Maisto; Angela P Leersnyder; Gwyneth L Pudner; Jonathan R Scheerer
Journal:  J Org Chem       Date:  2020-06-30       Impact factor: 4.354

6.  Derivatization of agelastatin A leading to bioactive analogs and a trifunctional probe.

Authors:  Morgan Jouanneau; Brandon McClary; Jeremy Chris P Reyes; Rong Chen; Yuling Chen; William Plunkett; Xin Cheng; Andrew Z Milinichik; Earl F Albone; Jun O Liu; Daniel Romo
Journal:  Bioorg Med Chem Lett       Date:  2016-02-23       Impact factor: 2.823

7.  Beyond the Divinyl Ketone: Innovations in the Generation and Nazarov Cyclization of Pentadienyl Cation Intermediates.

Authors:  William T Spencer; Tulaza Vaidya; Alison J Frontier
Journal:  European J Org Chem       Date:  2013-06-01

Review 8.  Dimeric pyrrole-imidazole alkaloids: synthetic approaches and biosynthetic hypotheses.

Authors:  Xiao Wang; Zhiqiang Ma; Xiaolei Wang; Saptarshi De; Yuyong Ma; Chuo Chen
Journal:  Chem Commun (Camb)       Date:  2014-05-15       Impact factor: 6.222

9.  Inhibition of Eukaryotic Translation by the Antitumor Natural Product Agelastatin A.

Authors:  Brandon McClary; Boris Zinshteyn; Mélanie Meyer; Morgan Jouanneau; Simone Pellegrino; Gulnara Yusupova; Anthony Schuller; Jeremy Chris P Reyes; Junyan Lu; Zufeng Guo; Safiat Ayinde; Cheng Luo; Yongjun Dang; Daniel Romo; Marat Yusupov; Rachel Green; Jun O Liu
Journal:  Cell Chem Biol       Date:  2017-04-27       Impact factor: 8.116

10.  Formal synthesis of (-)-agelastatin A: an iron(II)-mediated cyclization strategy.

Authors:  Daisuke Shigeoka; Takuma Kamon; Takehiko Yoshimitsu
Journal:  Beilstein J Org Chem       Date:  2013-05-03       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.